Found 250 Results
Page 7 of 13

PharmaJet partner Immunomic Therapeutics Initiates Clinical Trial of DNA Vaccine for Skin Cancer


GOLDEN, Colo. — March 15, 2022 — PharmaJet®, a biotech company that has developed a more effective way of administering drugs and biologics with their innovative, needle-free injection technology, announced that its partner Immunomic Therapeutics will be starting a phase 1 clinical study of their plasmid DNA vaccine ITI-3000 in patients with Merkel cell carcinoma (MCC), a rare but aggressive form of skin cancer.

Tags: ,

March 15, 2022

PharmaJet Vaccine Delivery featured at Sabin Vaccine Institute Conference


GOLDEN, Colo. — March 1, 2022 — PharmaJet®, a biotech company that has developed a more effective way of administering drugs and biologics with their innovative, needle-free injection technology, announced that their poster will be presented on March 1-3, 2022 at the Vaccination Acceptance Research Network (VARN) conference, sponsored by the Sabin Vaccine Institute. The poster, entitled Needle-free delivery of vaccines bridges vaccine coverage gaps in Somalia and Pakistan, is authored by J.V. Sannella (Gonzaga University), A.A. Obsie and M.Y. Elmi (World Health Organization, Global Polio Eradication Initiative), and K. Ngure and P. LaBarre (PharmaJet). This open conference (#VARN2022) will be held virtually, bringing together global experts, policymakers, practitioners, and social and behavioral science researchers.

Tags: ,

March 1, 2022

Stratis® Educational Video


Stratis® Educational Video This video provides a step-by-step guide to enhance your understanding of the PharmaJet Stratis Needle-free Injection System. You will learn how to properly prepare the Injector, accurately fill the Syringe, properly load the Injector with the filled Syringe, successfully administer an injection to a patient, and dispose of the used Syringe.

February 23, 2022

Tropis® Educational Video


Tropis® Educational Video This video provides a step-by-step guide to enhance your understanding of the PharmaJet Tropis Needle-free Injection System. You will learn how to properly prepare the Injector, accurately fill the Syringe, properly load the Injector with the filled Syringe, successfully administer an injection to a patient, and dispose of the used Syringe.

Regulatory Clearances


Regulatory Clearances For Regulatory Clearances, please contact PharmaJet.

February 15, 2022

PharmaJet partner Technovalia announces Interim results of Needle-free COVID-19 Vaccine Trial


GOLDEN, Colo. — February 15, 2022 — PharmaJet®, a biotech company that has developed a more effective way of administering drugs and biologics with their innovative, needle-free injection technology, announced that their partner, Technovalia, has reported interim safety results from their needle-free SARS-CoV2 DNA vaccine phase 1 trial. Interim safety data of COVIGEN, their DNA Covid-19 vaccine candidate, is well tolerated and no safety concerns were observed.

Tags: , , , , ,

PharmaJet CEO featured in CEOCFO Magazine


GOLDEN, Colo. — February 1, 2022 — PharmaJet®, a biotech company that has developed a more effective way of administering drugs and biologics with their innovative, needle-free injection technology, announced that Chris Cappello, President and CEO of PharmaJet was featured in CEOCFO Magazine.

Tags: , , ,

February 1, 2022

Needle-Free


Precision Delivery with Needle-free PharmaJet’s Needle-free Systems deliver a spring-powered injection in 1/10 of a second by means of a narrow stream of fluid that penetrates the skin with a precise dose and depth. No needle No external power source Fast and easy Talk to an expert Prequalified by the World Health Organization Our needle-free...

January 27, 2022

Nucleic Acid Vaccines


Needle-free Delivery of Nucleic Acid Vaccines Needle-free jet injection makes nucleic acid-based vaccines and therapeutics even better. Recipient Preference Caregiver Preference Safe and Effective Talk to an Expert Needle-free Can Improve Nucleic Acid Vaccines Nucleic acid vaccines have shifted the immunology landscape with unrivaled speed and impact. There is now sufficient evidence to conclude that...

COVID-19


Needle-free Delivery of COVID-19 Vaccines In collaboration with other leading biotechnology companies, we are leveraging our proprietary needle-free technology and our clinical expertise for the rapid development and delivery of vaccines and therapeutics to fight the COVID-19 pandemic. Recipient Preference Caregiver Preference Safe and Effective Find out more here Emergency Use Authorization of the World’s...

Needleless Flu Shot


Needle-free Delivery of an Influenza Vaccine The first vaccine in the US labeled for needle-free delivery. Recipient Preference Caregiver Preference Safe and Effective Find out more here Afluria® and Afluria QIV Influenza Vaccines are FDA Approved for use with the PharmaJet Stratis® Jet Injector Needle-free System The Stratis Needle-free Injector is the first needle-free jet...

January 21, 2022

Stratis


Stratis® IM/SC The Stratis Needle-free Injection System delivers accurate and consistent 0.5 mL intramuscular and subcutaneous injections to help you achieve better results with your pharma products. Completely needle-free Reduces injection hesitancy Minimal training required Download User Guide Stratis IM/SC Makes Your Pharma Products Better Improved Performance Your injectable products’ performance can be improved with...

January 20, 2022

Healthcare Provider Preference Survey – Stratis


Early in the 2014-2015 flu season, nearly 1,500 patients received a flu shot with the PharmaJet Needle-Free Injector at select retail pharmacies, a university flu shot event, a public health flu symposium, and a government research organization.

Pipeline


Pipeline PharmaJet’s Current Partnerships (Pre-Clinical Studies and Clinical Trials): Infectious Disease COVID-19 Pre-Clinical Studies DNA (12) RNA (2) Phase 1 Clinical Studies DNA (6) BioNet Asia COVIGEN DIOSynVax Scancell COVIDITY RNA (1) Phase 2 Clinical Studies DNA (1) Vaccibody VB D-01 Phase 3 Clinical Studies DNA (1) Zydus Cadila ZyCoV-D INFLUENZA Pre-Clinical Studies DNA (4)...

January 18, 2022

University of Cambridge begins COVID-19 Clinical Trial Using PharmaJet’s Needle-free System


GOLDEN, Colo. — January 18, 2022 — PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its Needle-free Injection System (NFIS) will be used in a clinical trial to deliver a booster vaccine against COVID-19 virus variants. The vaccine developed by DIOSynVax, a spinoff company supported by the University of Cambridge in the UK, recently announced the start of the Phase 1 clinical trial.

Tags: , , ,

Global Impact


Global Impact with Needle-free PharmaJet is making a global impact fighting polio with Tropis, our intradermal (ID) needle-free delivery system. Ideal for mass vaccination campaign Improved vaccine compliance Easy to roll out and train vaccinators Speak with an Expert Doing Our Part in the Next Step Towards Polio Eradication The latest 2022 WHO position paper...

January 10, 2022

Contact


We’d Love to Hear from You Contact information For general inquiries about our company and needle-free injection products, please feel free to contact our corporate headquarters at: Address: 400 Corporate Circle, Suite N Golden, Colorado, USA 80401 Tel: +1 888 900 4321 Tel Outside the U.S.: +1 303 526 4278 Sales: Email: [email protected] Fax: +1 303...

January 7, 2022

Terms and Conditions


Terms and Conditions The terms and conditions contained herein (these “Terms”) apply to all sales of products by PharmaJet, Inc. (“PharmaJet”) to the purchaser thereof (“Customer”) and shall govern irrespective of whether Customer accepts these Terms by a written acknowledgment, by implication, or by acceptance of, or payment for, products ordered. Any term, condition, or...

DMCA Policy


DMCA Policy If you feel any of the images or content on this site is in conflict with the Digital Millennium Copyright Act of 1998, please contact us.

Page 7 of 13